未登录

L

Liangding Hu

hematology

H指数:15

被引数:1,653

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2g/m2 Ara-c induced more favorable outcome than 1g/m2 Ara-c in CLAG treatment for refractory or relapsed acute myeloid leukemia without increase toxicity: a multicenter propensity score matching analysis

2g/m² Ara-c相比1g/m² Ara-c在CLAG治疗方案中对难治或复发性急性髓系白血病的治疗效果更优，且未增加毒性：一项多中心倾向性评分匹配分析

Annals of Hematology

IF2.4

2026-03-230

OAAI

First report of donor-derived active multiple myeloma from one AML patient after allogeneic stem cell transplantation

首例异基因干细胞移植后，1例急性髓系白血病患者发生供者来源的活跃性多发性骨髓瘤的报道

LEUKEMIA & LYMPHOMA

IF2.2

2025-12-010

PRE

Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain (vol 12, 85, 2023)

嵌合抗原受体T细胞移植PD1外膜域的靶向性和细胞毒性（卷12，85，2023）

hematology oncology

IF13.5

2025-04-020

OA

Long-term remission after fetal liver transplantation in acute leukemia: a 30-year follow-up report of two cases

STEM CELL RESEARCH & THERAPY

IF7.3

2025-02-100

OAAI

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: a multicentre, randomized, double-blind, phase 2 trial

IF8.3

2024-11-251

OAAI

Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-08-162

OAAI

Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-08-150

OAAI

Myeloproliferative neoplasm with eosinophilia and coexisting BCR::ABL1 and PDGFRB rearrangement: favorable and rapid response to imatinib

ANNALS OF HEMATOLOGY

IF2.4

2024-06-180

PRE

Targeting and cytotoxicity of chimeric antigen receptor T cells grafted with PD1 extramembrane domain

PD1膜外结构域移植的嵌合抗原受体T细胞的靶向性和细胞毒性

hematology oncology

IF13.5

2023-09-302

OAAI

Editorial: Novel mechanism and strategies to overcome relapse after allogeneic stem cell transplantation

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-07-110

OAAI

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group

IF3.6

2023-04-017

OAAI

Ai, Huisheng; Chao, Nelson J.; Rizzieri, David A.; Huang, Xiaojun; Spitzer, Thomas R.; Wang, Jianxiang; Guo, Mei; Keating, Armand; Krakow, Elizabeth F.; Blaise, Didier; Ma, Jun; Wu, Depei; Reagan, John; Gergis, Usama; Duarte, Rafael F.; Chaudhary, Preet M.; Hu, Kaixun; Yu, Changlin; Sun, Qiyun; Fuchs, Ephraim; Cai, Bo; Huang, Yajing; Qiao, Jianhui; Gottlieb, David; Schultz, Kirk R.; Liu, Mingyao; Chen, Xiequn; Chen, Wenming; Wang, Jianmin; Zhang, Xiaohui; Li, Jianyong; Huang, He; Sun, Zimin; Li, Fei; Yang, Linhua; Zhang, Liansheng; Li, Lijuan; Liu, Kaiyan; Jin, Jie; Liu, Qifa; Liu, Daihong; Gao, Chunji; Fan, Chuanbo; Wei, Li; Zhang, Xi; Hu, Liangding; Zhang, Weijing; Tian, Yuyang; Han, Weidong; Zhu, Jun; Xiao, Zhijian; Zhou, Daobin; Zhang, Bolong; Jia, Yongqian; Zhang, Yongqing; Wu, Xiaoxiong; Shen, Xuliang; Lu, Xuzhang; Zhan, Xinrong; Sun, Xiuli; Xiao, Yi; Wang, Jingbo; Shi, Xiaodong; Zheng, Bo; Chen, Jieping; Ding, Banghe; Wang, Zhao; Zhou, Fan; Zhang, Mei; Zhang, Yizhuo; Sun, Jie; Xia, Bing; Chen, Baoan; Ma, Liangming

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study

FRONTIERS IN ONCOLOGY

IF3.3

2022-07-184

OAAI

Single-cell RNA sequencing reveals the landscapes of human cord blood hematopoietic stem cell differentiation during ex vivo culture

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2021-11-081

OAAI

CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report

CD19和CD22 car-t细胞衰竭后，具有膜结合IL-15的b细胞急性淋巴细胞白血病的CD19 car-t细胞: 病例报告

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-10-0718

OAAI

Cytoplasmic NEAT1 Suppresses AML Stem Cell Self-Renewal and Leukemogenesis through Inactivation of Wnt Signaling

胞质NEAT1通过失活Wnt信号抑制AML干细胞自我更新和白血病发生

ADVANCED SCIENCE

IF14.1

2021-10-0530

OA

A Retrospective Observation of Treatment Outcomes Using Decitabine-Combined Standard Conditioning Regimens Before Transplantation in Patients With Relapsed or Refractory Acute Myeloid Leukemia

FRONTIERS IN ONCOLOGY

IF3.3

2021-08-2411

OAAI

A multicenter retrospective study on the real-world outcomes of autologous vs. allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphoma in China

CHINESE MEDICAL JOURNAL

IF7.3

2021-07-054

OAAI

Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-04-018

OAAI

Myeloablative Haploidentical Transplant as an Alternative to Matched Sibling Transplant for Peripheral T-Cell Lymphomas

CELL TRANSPLANTATION

IF3.2

2021-03-210

OAAI

Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy

IF3.2

2020-12-0121

PREAI